Semax

Semax is identified by the seven-residue sequence Met-Glu-His-Phe-Pro-Gly-Pro, commonly abbreviated MEHFPGP. QURE’s Semax research product is listed at 10mg. The chemical name refers to a specific heptapeptide, not a general category of neurological research materials.

Its structure combines an ACTH-related four-residue segment with a Pro-Gly-Pro ending. That sequence context helps distinguish Semax in scientific literature while keeping the complete molecule separate from ACTH itself. Short peptide fragments and their modified analogues should not be treated as identical simply because they share part of a sequence.

Semax and Selank both contain seven residues and the same final three-residue segment. Their remaining residues differ, producing distinct peptide identities. Comparing their full sequences is more informative than comparing only the length or the abbreviated product names.

For this listing, 10mg is the stated material quantity. It does not define a prepared concentration or suggest a particular procedure. Research publications about Semax provide background on the molecule but cannot establish the analytical properties of QURE’s individual lots.

Consult the COA document library for current material records where listed. The description makes no cognitive, performance, or therapeutic promises and does not claim an outcome from using the material in an experiment.

For research use only. Not for human or veterinary use, consumption, or administration.